All Oregon Health & Science University articles
-
NewsDangerous E. coli strain blocks gut’s defense mechanism to spread infection
When harmful bacteria invade through the digestive tract, gut cells usually fight back by pushing infected cells out of the body to stop the infection from spreading. Scientists have discovered that a dangerous strain of E. coli can block gut this defense, allowing the bacteria to spread more easily.
-
NewsResearchers partner on $28M initiative to build a precision phage platform for promoting public health
Researchers have embarked on a five-year initiative that aims to harness the natural predators of bacteria – known as phages – as precision tools to shape the human microbiome and promote health.
-
NewsMERIT grant awarded to study cure for HIV
A scientific team has received an NIH MERIT Award to provide long-term grant support to study a handful of people who have managed to clear HIV after a stem cell transplant and those who did not.
-
NewsReview suggests ending adult boosters for tetanus, diphtheria
The United States could safely drop tetanus and diphtheria booster shots for adults and save an estimated $1 billion a year, according to a new review. The safety and savings depend on maintaining strong childhood vaccination rates, researchers emphasized.
-
NewsStudy finds new targets needed for vaccine to prevent herpesvirus transmission to babies
Despite the lack of research on vaccines against congenital cytomegalovirus (CMV), a research has recently discovered that the virus is able to cause cross-placental transmission even with the absence of multple essential proteins, providing insights for future vaccine development.
-
NewsStudy shows promise for a universal influenza vaccine
New research reveals a promising approach to developing a universal influenza vaccine — a so-called “one and done” vaccine that confers lifetime immunity against an evolving virus.
-
NewsSRI is developing a new malaria treatment that aims to protect from the disease
The injectable formulation is affordable, easily administered, and could potentially provide months of protection from the potentially fatal disease.
-
NewsStaying current with COVID-19 vaccinations helps combat emerging variants
The study is among the first to test in a biosafety level 3 laboratory whether vaccine-elicited antibodies block infection of a live virus.
-
NewsNew blood test cuts infection diagnosis time from months to hours
Researchers have designed a platform to perform blood-based diagnoses of nontuberculosis mycobacteria, simplifying and shortening a long-complicated procedure from 6 months to 2 hours.
-
NewsOur bacteria are more personal than we thought, study shows
The trillions of bacteria that call your body home appear to be unique to you, like a fingerprint, concludes a detailed study of the gut, mouth, nose and skin microbiomes of 86 people.
-
NewsLab-made antibodies offer potential cure for yellow fever
New research indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.
-
NewsPotential drug takes aim at emerging Chikungunya virus
Researchers are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.